Aducanumab continues to rack up positive numbers in phase 1b open-label extensionNovember 3, 2017Alzheimer's & Cognition
In Lewy body disease, CSF may reveal dementia riskNovember 3, 2017Alzheimer's & CognitionMovement Disorders
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentumNovember 2, 2017Alzheimer's & Cognition
Lumateperone shows broad phase 3 potential for psychiatric disordersOctober 29, 2017Alzheimer's & Cognition
AF patients without oral anticoagulation face higher dementia riskOctober 26, 2017StrokeAlzheimer's & Cognition
Post-Ebola syndrome includes neurologic sequelaeOctober 15, 2017PainAlzheimer's & CognitionRare Diseases
Plenary sessions at ANA 2017 cover wide spectrum of neurologic topicsOctober 6, 2017Movement DisordersAlzheimer's & CognitionEpilepsy & SeizuresNeuromuscular Disorders
Higher BP targets suggested for elderly, cognitively impairedSeptember 27, 2017Alzheimer's & CognitionStroke
Study linked H2 receptor antagonists, but not PPIs, to dementiaSeptember 5, 2017Alzheimer's & Cognition
